TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.

Sonia Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.